Cormorant Asset Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001583977

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2023 · 48 positions · Total reported value $2.09B · Top-10 concentration 62.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 81.4% · 9 new · 37 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -24.1% · vs SPY -26.2% · Prev Value $1.95B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -13.0% · vs SPY -15.1% · Latest Value $1.40B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, Cormorant Asset Management, LP disclosed 48 equity positions with a combined reported value of $2.09B. The filing implies a focused portfolio: its ten largest positions account for 62.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were MLTX ($512.96M), AMAM ($159.93M), EYPT ($139.54M). By sector, the heaviest allocations are Health Care 61.4%, Industrials 6.7%. Versus the prior quarter, allocation shifted toward Industrials (+5.2pp), Other (+1.1pp) and away from Health Care (-6.3pp).

Versus the prior quarter, Cormorant Asset Management, LP opened 9 new positions, trimmed 37 and fully exited 2, a turnover rate of 81.4% of positions. The portfolio's overlap with the prior quarter was 67% of names.

The largest new positions opened in Q4 2023 were CRGX ($27.38M), SNDX ($25.39M), KRRO ($25.36M).

Of the 2 positions fully exited versus the prior quarter, the largest were GPCR ($53.26M), CABA ($43.82M), KRTX ($23.67M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • CRGX CARGO THERAPEUTICS INC · $27.38M
  • SNDX SYNDAX PHARMACEUTICALS INC · $25.39M
  • KRRO KORRO BIO INC · $25.36M
  • ABVX ABIVAX SA · $22.79M
  • SYRE SPYRE THERAPEUTICS INC · $20.17M
  • NGNE NEUROGENE INC · $14.46M
  • EDIT EDITAS MEDICINE INC · $5.07M
  • LNTH LANTHEUS HLDGS INC · $4.65M

Fully Exited (vs previous quarter)

  • GPCR STRUCTURE THERAPEUTICS INC · prev qtr: $53.26M
  • CABA CABALETTA BIO INC · prev qtr: $43.82M · history
  • KRTX KARUNA THERAPEUTICS INC · prev qtr: $23.67M
  • ERAS ERASCA INC · prev qtr: $21.30M · history
  • ELVN ENLIVEN THERAPEUTICS INC · prev qtr: $16.62M · history
  • ZNTL ZENTALIS PHARMACEUTICALS INC · prev qtr: $14.04M
  • RNAM AVIDITY BIOSCIENCES INC · prev qtr: $11.24M
  • COGT COGENT BIOSCIENCES INC · prev qtr: $9.75M

Insider Transactions (Form 4)

Latest Cormorant Asset Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-29 Sell Corbus Pharmaceuticals Holdings, Inc. 425,000 $4.10 SEC filing
2026-08-10 Buy BlossomHill Therapeutics, Inc. 312,500 $16.00 SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,701,541 — SEC filing
2026-08-10 Conversion BlossomHill Therapeutics, Inc. 1,599,993 — SEC filing
2026-04-28 Sell BRIGHT MINDS BIOSCIENCES INC. 109,331 $89.50 SEC filing

All insider transactions →

Fund Profile

Cormorant Asset Management, LP, based in Boston, MA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 57 positions worth $1.40B in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-79513 (status: Approved), registered 2014-04-15
  • Regulatory AUM (Form ADV): $3.84B as of 2026-05-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 57 positions · $1.40B reported value (Q3 2026)
  • Top 10 holdings = 56.4% of reported value
  • Largest position: PBLS (PARABILIS MEDICINES INC) at 10.7%
  • Average position size: $24.53M

Sector Tilt

  • Health Care 92.7%
  • Industrials 1.3%
  • Financials 1.1%
  • (classified holdings cover 95% of value)

Quarterly Activity

  • Q3 2026: 9 new, 1 added, 37 reduced, 2 exited
  • 10 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 61.4%
Materials 0.1%
Other 31.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 8.49M $512.96M 24.50%
24.50%
Add
2 11.23M $159.93M 7.64%
7.64%
Add
3 6.04M $139.54M 6.66%
6.66%
Add
4 3.34M $135.00M 6.45%
6.45%
Reduce
5 1.70M $94.35M 4.51%
4.51%
Reduce
6 1.21M $75.44M 3.60%
3.60%
Add
7 3.57M $51.85M 2.48%
2.48%
Hold
8 1.17M $49.08M 2.34%
2.34%
Reduce
9 2.55M $48.60M 2.32%
2.32%
Add
10 1.71M $48.01M 2.29%
2.29%
Add
11 3.14M $46.79M 2.23%
2.23%
Add
12 2.22M $44.98M 2.15%
2.15%
Reduce
13 1.80M $42.52M 2.03%
2.03%
Reduce
14 665.00K $41.76M 1.99%
1.99%
Hold
15 1.15M $40.92M 1.95%
1.95%
Add
16 625.00K $37.41M 1.79%
1.79%
Reduce
17 3.25M $35.33M 1.69%
1.69%
Add
18 5.45M $35.10M 1.68%
1.68%
Add
19 2.46M $34.47M 1.65%
1.65%
Reduce
20 4.20M $30.90M 1.48%
1.48%
Hold
21 2.55M $27.92M 1.33%
1.33%
Reduce
22 1.21M $27.42M 1.31%
1.31%
Reduce
23 1.18M $27.38M 1.31%
1.31%
New
24 1.18M $25.39M 1.21%
1.21%
New
25 529.17K $25.36M 1.21%
1.21%
New
26 550.00K $25.28M 1.21%
1.21%
Reduce
27 2.13M $22.79M 1.09%
1.09%
New
28 2.35M $22.55M 1.08%
1.08%
Add
29 937.08K $20.17M 0.96%
0.96%
New
30 575.00K $17.82M 0.85%
0.85%
Hold
31 450.00K $16.01M 0.77%
0.77%
Reduce
32 250.00K $15.56M 0.74%
0.74%
Hold
33 746.18K $14.46M 0.69%
0.69%
New
34 2.35M $14.19M 0.68%
0.68%
Hold
35 633.35K $14.11M 0.67%
0.67%
Reduce
36 450.00K $13.49M 0.64%
0.64%
Hold
37 496.75K $12.34M 0.59%
0.59%
Add
38 125.00K $7.22M 0.34%
0.34%
Reduce
39 1.09M $5.72M 0.27%
0.27%
Hold
40 500.00K $5.07M 0.24%
0.24%
New
41 350.00K $4.88M 0.23%
0.23%
Hold
42 75.00K $4.65M 0.22%
0.22%
New
43 561.60K $4.47M 0.21%
0.21%
Hold
44 81.96K $3.51M 0.17%
0.17%
Hold
45 593.04K $3.44M 0.16%
0.16%
Hold
46 1.39M $3.25M 0.15%
0.15%
New
47 1.18M $2.91M 0.14%
0.14%
Hold
48 92.29K $1.57M 0.07%
0.07%
Hold

FAQ

What did Cormorant Asset Management, LP buy in 2023-Q4?

In its 2023-Q4 13F filing, Cormorant Asset Management, LP reported 48 equity positions worth $2.09B in aggregate; its largest disclosed positions were MLTX ($512.96M), AMAM ($159.93M), EYPT ($139.54M).

How large is Cormorant Asset Management, LP's portfolio?

Cormorant Asset Management, LP reported $2.09B of long equity holdings across 48 positions as of 2023-Q4. Top-10 holdings account for 62.8% of reported value.

What is Cormorant Asset Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/cormorant-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →